Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | COMT | P21964 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10100825 | 0.87 | KDM4E (0.50) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL13872357 | 0.87 | KDM4E (0.38) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL18690040 | 0.85 | KDM4E (0.42) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL1322395 | 0.85 | KDM4E (0.52) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL12454703 | 0.85 | KDM4E (0.52) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL3779321 | 0.85 | KDM4E (0.52) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL13957177 | 0.85 | KDM4E (0.52) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL4406988 | 0.85 | KDM4E (0.52) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL13872311 | 0.85 | KDM4E (0.39) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 | |
| SCHEMBL31663511 | 0.85 | KDM4E (0.49) | KDM4EL3MBTL1ATMAKR1C4AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324403-B2 | Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime | PIONEER CORPORATION (JP) | 2012-12-04 | — | — | US | disclosed |
| US-8324403-B2 | Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime | PIONEER CORPORATION (JP) | 2012-12-04 | — | — | US | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | PIONEER CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | PIONEER CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | KDM4E 2880/4885L3MBTL1 690/4885ATM 4296/4885 |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | SLC39A3, SLCO2A1, SLC39A11 | KDM4E 3607/4885L3MBTL1 1312/4885ATM 3886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.